# Follow up After Cryoablation of Small Renal Masses.

> **NCT02411968** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 9 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

- **OTHER:** 111In-Girentuximab DOTA SPECT

## Key facts

- **NCT ID:** NCT02411968
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2019-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02411968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02411968, "Follow up After Cryoablation of Small Renal Masses.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02411968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*